journal article·2026-01

Dynamic cell patterning and photopolymerization with electric field modulation for constructing hierarchical tumor microenvironments

Anping Wu, Yanfeng Zhao, Xinyi Dong, Jiaxin Liu, Zhiqiang Zheng, Qing Shi, Toshio Fukuda, Huaping Wang

Acta Biomaterialia· Volume 209
Publisher page

Abstract

Engineered tumor models that replicate the hierarchical, heterogeneous microenvironment of in vivo tumors have shown huge potential in biomedical and clinical research. Tumor spheroids are widely used as in vitro models to investigate tumor pathophysiology. However, due to the complex cell-cell and cell-extracellular matrix (ECM) interactions in native tumor tissues, tumor spheroids alone often fail to replicate the intricate architecture and functionality of the tumor microenvironment (TME). Here, we propose a versatile strategy that assembles tumor spheroids while simultaneously constructing individualized ECM-mimicking environments, thereby more accurately replicating the native hierarchical TME. By applying a uniform electric field, the wettability of cell-laden hydrogel droplets is modulated, enabling their transport to predefined locations. Once positioned, a non-uniform electric field induces dielectrophoresis (DEP), guiding the cells to aggregate into tumor spheroids following predefined patterns. A digital micromirror device (DMD) then dynamically controls the shape and position of ultraviolet (UV) patterns, triggering photopolymerization of the hydrogel and precisely encapsulating the cell spheroids, thereby forming tumor models. In our experiment, breast cancer and liver cancer cells were aggregated to form tumor spheroids that maintained high cell viability, proliferative capacity, and morphological regularity, with the spheroid circularity reaching 0.84. Furthermore, when liver cancer spheroids were encapsulated in hydrogels containing endothelial cells, their invasiveness increased by approximately 77 %. We anticipate that our method will be capable of regenerating more complex tumor models with unprecedented possibilities for future drug discovery. STATEMENT OF SIGNIFICANCE: Reconstructing a hierarchical tumor microenvironment (TME) requires not only the formation of cell aggregates with natural intercellular connections but also the precise spatial organization of stromal cells and extracellular matrix components (ECM). However, achieving such dynamic cellular assembly and controllable heterogeneity during bioprinting remains challenging. Here, we present a multifunctional strategy that integrates dielectrophoretic droplet manipulation into a 3D bioprinting system to induce the in situ formation of compact, viable, and uniform tumor spheroids. Bioinks containing ECM components and stromal cells are then spatially patterned and photopolymerized with high precision to build customizable, biomimetic TMEs. This approach provides a versatile and controllable platform for drug screening, cancer research, and personalized medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Micro-engineering and nano-engineering approaches to investigate tumour ecosystems10.1038/s41568-023-00593-3 ↗
2. Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments10.1038/s41420-025-02505-w ↗
3. Spatial landscapes of cancers: insights and opportunities10.1038/s41571-024-00926-7 ↗
4. Genomic map of the cellular composition of the tumor microenvironment10.1038/s41590-024-01964-0 ↗
5. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth10.1016/j.ccell.2023.02.016 ↗
6. Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers10.1038/s41467-025-56279-x ↗
7. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment10.1038/s41588-022-01141-9 ↗
8. Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical models of cervical cancer10.1038/s41419-025-07402-9 ↗
9. The interplay of the extracellular matrix and stromal cells as a drug target in stroma-rich cancers10.1016/j.tips.2020.01.001 ↗
10. Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis10.1038/mt.2013.181 ↗
11. Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment10.1038/s41467-025-60448-3 ↗
12. Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment10.1038/s41590-025-02178-8 ↗
13. High resolution lithography 3D bioprinting10.1016/j.tibtech.2022.11.007 ↗
14. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment10.1126/sciadv.abi9119 ↗
15. 3D printed in vitro tumor tissue model of colorectal cancer10.7150/thno.52450 ↗
16. Visible light-induced 3D bioprinting technologies and corresponding bioink materials for
17. Inkjet printing and 3D printing strategies for biosensing, analytical, and diagnostic applications10.1002/adma.202105015 ↗
18. Grayscale digital light processing 3D printing for highly functionally graded materials10.1126/sciadv.aav5790 ↗
19. A smartphone-enabled portable digital light processing 3D printer10.1002/adma.202170271 ↗
20. Generation of a perfusable 3D lung cancer model by digital light processing10.3390/ijms24076071 ↗
21. Opportunities and challenges of translational 3D bioprinting10.1038/s41551-019-0471-7 ↗
22. Permeable hollow 3D tissue-like constructs engineered by on-chip hydrodynamic-driven assembly of multicellular hierarchical micromodules10.1016/j.actbio.2020.06.010 ↗
23. Rocking- and diffusion-based culture of tumor spheroids-on-a-chip10.1039/D3LC01116J ↗
24. Scalable formation of highly viable and functional hepatocellular carcinoma spheroids in an oxygen-permeable microwell device for anti-tumor drug evaluation
25. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array10.1039/C0AN00609B ↗
26. Three-dimensional culture systems in cancer research: focus on tumor spheroid model10.1016/j.pharmthera.2016.03.013 ↗
27. Engineered biomaterials to guide spheroid formation, function, and fabrication into 3D tissue constructs10.1016/j.actbio.2022.09.052 ↗
28. Generation of tumor spheroids using a droplet-based microfluidic device for photothermal therapy10.1038/s41378-020-0167-x ↗
29. Tumor proliferation and invasion are intrinsically coupled and unraveled through tunable spheroid and physics-based models10.1016/j.actbio.2023.12.043 ↗
30. A review of manufacturing capabilities of cell spheroid generation technologies and future development10.1002/bit.27620 ↗
31. Magnetic molding of tumor spheroids: emerging model for cancer screening10.1088/1758-5090/abc670 ↗
32. Acoustic formation of multicellular tumor spheroids enabling on-chip functional and structural imaging10.1039/C8LC00537K ↗
33. Hydraulic and electric control of cell spheroids10.1073/pnas.2021972118 ↗
34. Remote magnetic nanoparticle manipulation enables the dynamic patterning of cardiac tissues10.1002/adma.201904598 ↗
35. Patterned three-dimensional encapsulation of embryonic stem cells using dielectrophoresis and stereolithography10.1002/adhm.201200318 ↗
36. Mechanical communication in fibrosis progression10.1016/j.tcb.2021.10.002 ↗
37. Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling10.1038/s41392-023-01453-0 ↗
38. The intriguing role of collagen on the rheology of cancer cell spheroids10.1016/j.jbiomech.2022.111229 ↗
39. Collagen reorganization at the tumor-stromal interface facilitates local invasion10.1186/1741-7015-4-38 ↗
40. The extracellular matrix modulates the metastatic journey10.1016/j.devcel.2019.03.026 ↗
41. Modulating angiogenesis by proteomimetics of vascular endothelial growth factor10.1021/jacs.1c09571 ↗
42. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response10.1136/jitc-2020-001038 ↗
43. Strategy for treatment of infected diabetic foot ulcers10.1021/acs.accounts.0c00864 ↗